一个全面的审查的抗癌作用的decursin
Yueming Chu1,2, Qiang Yuan1,2, Hangyu Jiang1,2
1Department of Pharmacy, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, China.
Frontiers in pharmacology
|March 6, 2024
概括
德库尔辛是一种来自Angelica sinensis的天然化合物,具有强大的抗癌活性,并增强化疗效率. 它在预防和治疗癌症方面的潜力需要进一步的临床研究.
科学领域:
- 自然产品 化学 化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 癌症带来复杂的挑战,随着药物耐药性的增加.
- 天然产品具有强大的抗癌活性,具有低毒性.
- 德库辛是来自Angelica sinensis的一种库马林,表现出各种生物活动.
研究的目的:
- 为了审查decursin的抗癌潜力.
- 探索decursin的作用机制和治疗应用.
- 评估dcursin的安全性和与常规疗法的协同效应.
主要方法:
- 关于decursin生物活性研究的文献综述.
- 对decursin对癌细胞增殖,细胞亡和转移的影响的分析.
- 对decursin在瘤微环境和耐药性中的作用的评估.
主要成果:
- 德库辛影响癌细胞的增殖,细胞亡,自,血管新生和转移.
- 德库辛与临床抗癌药物具有协同作用,增强敏感性和逆转耐药性.
- 德库尔辛及其衍生物显示出有前途的抗癌作用,具有良好的安全性.
结论:
- 德库辛是一种有前途的天然化合物,用于预防和治疗癌症.
- 德库辛能够增强化疗和克服药物耐药性的能力凸显了其治疗价值.
- 需要进一步的研究来将decursin的实验室潜力转化为临床应用.
更多相关视频
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.4K
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
890
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
163
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
163
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
